Retrophin (RTRX) Shares Declined While Perceptive Advisors Lifted Position by $333,480; Mivtachim The Workers Social Insurance Fund LTD Upped Its Mylan N V Shs Euro (MYL) Stake by $4.29 Million as Stock Price Declined

January 14, 2018 - By Peter Erickson

Joseph Edelman increased its stake in Retrophin Inc (RTRX) by 0.52% based on its latest 2017Q3 regulatory filing with the SEC. Perceptive Advisors Llc bought 13,895 shares as the company’s stock declined 17.61% while stock markets rallied. The hedge fund run by Joseph Edelman held 2.69M shares of the health care company at the end of 2017Q3, valued at $66.86 million, up from 2.67 million at the end of the previous reported quarter. Perceptive Advisors Llc who had been investing in Retrophin Inc for a number of months, seems to be bullish on the $970.88M market cap company. The stock decreased 0.20% or $0.05 during the last trading session, reaching $24.7. About 228,457 shares traded. Retrophin, Inc. (NASDAQ:RTRX) has risen 4.93% since January 14, 2017 and is uptrending. It has underperformed by 11.77% the S&P500.

Mivtachim The Workers Social Insurance Fund Ltd increased its stake in Mylan N V Shs Euro (MYL) by 6.37% based on its latest 2017Q3 regulatory filing with the SEC. Mivtachim The Workers Social Insurance Fund Ltd bought 138,500 shares as the company’s stock declined 9.77% while stock markets rallied. The institutional investor held 2.31 million shares of the major pharmaceuticals company at the end of 2017Q3, valued at $72.52M, up from 2.17M at the end of the previous reported quarter. Mivtachim The Workers Social Insurance Fund Ltd who had been investing in Mylan N V Shs Euro for a number of months, seems to be bullish on the $25.16B market cap company. The stock increased 0.41% or $0.19 during the last trading session, reaching $46.9. About 6.04 million shares traded or 1.30% up from the average. Mylan N.V. (NASDAQ:MYL) has declined 7.73% since January 14, 2017 and is downtrending. It has underperformed by 24.43% the S&P500.

Among 21 analysts covering Mylan Inc. (NASDAQ:MYL), 13 have Buy rating, 0 Sell and 8 Hold. Therefore 62% are positive. Mylan Inc. had 60 analyst reports since July 27, 2015 according to SRatingsIntel. The company was upgraded on Monday, October 10 by Raymond James. The stock of Mylan N.V. (NASDAQ:MYL) earned “Buy” rating by Deutsche Bank on Tuesday, July 28. Leerink Swann maintained it with “Outperform” rating and $60 target in Saturday, August 29 report. The company was maintained on Wednesday, August 9 by Cantor Fitzgerald. The stock of Mylan N.V. (NASDAQ:MYL) has “Hold” rating given on Tuesday, August 22 by Argus Research. Leerink Swann maintained Mylan N.V. (NASDAQ:MYL) rating on Monday, August 15. Leerink Swann has “Outperform” rating and $55 target. The rating was maintained by Cantor Fitzgerald with “Hold” on Thursday, December 21. As per Friday, November 13, the company rating was upgraded by Citigroup. Susquehanna maintained it with “Buy” rating and $47.0 target in Tuesday, November 7 report. Cowen & Co downgraded the stock to “Market Perform” rating in Monday, July 27 report.

Mivtachim The Workers Social Insurance Fund Ltd, which manages about $1.59B US Long portfolio, decreased its stake in Perrigo Co Plc Shs (NYSE:PRGO) by 54,000 shares to 140,656 shares, valued at $11.91M in 2017Q3, according to the filing.

Investors sentiment decreased to 0.33 in Q3 2017. Its down 1.00, from 1.33 in 2017Q2. It fall, as 3 investors sold MYL shares while 0 reduced holdings. 1 funds opened positions while 0 raised stakes. 155,019 shares or 7.99% less from 168,486 shares in 2017Q2 were reported. Gulf State Bank (Uk) Ltd holds 0.06% or 139,930 shares in its portfolio. Vantage Inv Advsrs Ltd Llc holds 0.01% of its portfolio in Mylan N.V. (NASDAQ:MYL) for 712 shares.

Among 4 analysts covering Retrophin (NASDAQ:RTRX), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Retrophin had 7 analyst reports since August 12, 2015 according to SRatingsIntel. As per Friday, October 6, the company rating was maintained by BMO Capital Markets. The rating was maintained by BMO Capital Markets with “Buy” on Tuesday, November 7. The rating was downgraded by Zacks to “Buy” on Wednesday, August 12. BMO Capital Markets initiated Retrophin, Inc. (NASDAQ:RTRX) rating on Tuesday, April 12. BMO Capital Markets has “Outperform” rating and $25 target. JMP Securities initiated Retrophin, Inc. (NASDAQ:RTRX) rating on Monday, November 2. JMP Securities has “Mkt Outperform” rating and $30 target.

Investors sentiment increased to 1.62 in 2017 Q3. Its up 0.46, from 1.16 in 2017Q2. It is positive, as 12 investors sold RTRX shares while 25 reduced holdings. 20 funds opened positions while 40 raised stakes. 40.07 million shares or 1.15% more from 39.61 million shares in 2017Q2 were reported. Citadel Ltd Liability Corp, Illinois-based fund reported 410,837 shares. California Public Employees Retirement System invested in 0% or 51,001 shares. Emory University holds 1.46% or 73,917 shares. Ameriprise has 30,090 shares for 0% of their portfolio. Fisher Asset Ltd Liability Company owns 0% invested in Retrophin, Inc. (NASDAQ:RTRX) for 75,645 shares. Tiaa Cref Management Limited Liability Com holds 652,052 shares or 0.01% of its portfolio. Citigroup Incorporated invested in 0% or 18,633 shares. Sphera Funds Mngmt Ltd holds 0.62% in Retrophin, Inc. (NASDAQ:RTRX) or 174,131 shares. Nationwide Fund Advsr holds 57,776 shares or 0.01% of its portfolio. Royal Savings Bank Of Canada has invested 0% of its portfolio in Retrophin, Inc. (NASDAQ:RTRX). Deutsche Bank & Trust Ag has 0.01% invested in Retrophin, Inc. (NASDAQ:RTRX) for 675,454 shares. Principal holds 0% of its portfolio in Retrophin, Inc. (NASDAQ:RTRX) for 21,334 shares. 11,900 were reported by Arrowstreet Cap Ltd Partnership. Swiss Retail Bank reported 59,700 shares or 0% of all its holdings. Campbell Investment Adviser Ltd holds 10,017 shares.

Since August 16, 2017, it had 0 insider purchases, and 2 sales for $53,651 activity. $22,646 worth of Retrophin, Inc. (NASDAQ:RTRX) was sold by REED ELIZABETH E.

Perceptive Advisors Llc, which manages about $2.09 billion and $2.62 billion US Long portfolio, decreased its stake in Alnylam Pharmaceuticals Inc (Call) (NASDAQ:ALNY) by 1.73M shares to 100,000 shares, valued at $2.32M in 2017Q3, according to the filing. It also reduced its holding in Dbv Technologies S A by 15,346 shares in the quarter, leaving it with 576,419 shares, and cut its stake in Aveo Pharmaceuticals Inc (NASDAQ:AVEO).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>